Please respond to my colleague’s post below, you don’t have to contradict what she said on her treatment. You can put more suggestion on treatment or additional education. Please have three or more references. Thank you!
Case Study Group 1
Patient HH is a 68-year-old male with a history of COPD, HTN, and diabetes, which makes him susceptible to respiratory infections like community acquired pneumonia (CAP) (Pillai, Sabnis, Biswas, 2019). It appears antibiotic therapy has improved patient HH’s condition because he requires less oxygen. The problem is that he is not tolerating a diet and cannot be started on PO antibiotics. According to Cao et al. (2017), the patient does not meet discharge criteria until he is tolerating PO meds. It is important to note that he is allergic to penicillin and close monitoring of his kidney function and labs is indicated because of his age and medical history.
Get Assignment Writing Help
Our experts are ready to complete your assignment, course work. essay, test, dissertation, research paper, quizGet Started
Patient treatment will include a respiratory quinolone Levaquin. The previous antibiotics will be discontinued. The starting dose would be 750mg IV q24 for 5 days. Cao et al. (2017), believe this treatment is part of the initial treatment for CAP in patients older than 65 years with comorbidities. This treatment is also recommended by the Infectious Disease Society of America/American Thoracic Society and has shown clinical improvement in elderly patients (National Library of Medicine National Institutes of Health, 2014). If patient tolerates PO, Levaquin can be administered PO. It is important to note, that if the etiology of CAP is known, targeted therapies can be given depending on susceptibility testing (Cao et al., 2017).
It is crucial to print out all information about the new treatment, including expected side effects, adverse effects, length of treatment, and dosages. The patient should be able to have the information printed if certain information is forgotten. It is as important to include a family member in the teaching and explain consequences of not adhering to prescribed meds.
RESOURCES:( Please use one or two of these resources on top of other resources you may use for references)
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advacned practice providers. St. Louis, MO: Elsevier.
- Chapter 44, “Anticoagulant and Antiplatelet Drugs” (pp. 451–472)
- Chapter 45, “Drugs for Deficiency Anemias” (pp. 473–483)
- Chapter 48, “Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications” (pp. 521–533)
- Chapter 49, “Birth Control” (pp. 535–547)
- Chapter 50, “Androgens” (pp. 549–556)
- Chapter 51, “Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia” (pp. 557–569)
- Chapter 68, “Basic Principles of Antimicrobial Therapy” (pp. 769–781)
- Chapter 69, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp. 783–790)
- Chapter 73, “Sulfonamides and Trimethoprim” (pp. 619–826)
- Chapter 74, “Drug Therapy of Urinary Tract Infections” (pp. 827–831)
- Chapter 75, “Antimycobacterial Agents” (pp. 833–847)
- Chapter 76, “Miscellaneous Antibacterial Drugs” (pp. 849–853)
- Chapter 77, “Antifungal Agents” (pp. 855–866)
- Chapter 78, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 867–886)
- Chapter 80, “Drug Therapy of Sexually Transmitted Diseases” (pp. 905–911)
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male, 18(1), 5–15. doi:10.3109/13685538.2015.1004049
This article presents recommendations on the diagnosis, treatment, and monitoring of hypogonadism in men. Reflect on the concepts presented and consider how this might impact your role as an advanced practice nurse in treating men’s health disorders.
Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., … Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS ONE, 9(2), e87872. Retrieved from https://doi.org/10.1371/journal.pone.0087872
This study examines HAART therapy and its sustainability and profound population-level decrease in morbidity, mortality, and HIV transmission.
Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas, 86(2016), 53–58. .https://doi.org/10.1016/j.maturitas.2016.01.007
This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction, and mood disturbance that are common during the menopause transition.
Agency for Healthcare Research and Quality. (2014). Guide to clinical preventive services, 2014: Section 2. Recommendations for adults. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/section2.html
This website lists various preventive services available for men and women and provides information about available screenings, tests, preventive medication, and counseling.
Stuck with a Question?
Get it solved from our top experts within 8 hrs!Ask Your Question Now!